ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 34 filers reported holding ETON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $907,754 | +23.8% | 217,629 | +3.6% | 0.00% | – |
| Q2 2023 | $733,221 | +2.1% | 210,092 | +12.6% | 0.00% | – |
| Q1 2023 | $718,340 | +137513.0% | 186,582 | 0.0% | 0.00% | – |
| Q4 2022 | $522 | -99.9% | 186,582 | -0.2% | 0.00% | – |
| Q3 2022 | $392,000 | -19.8% | 186,971 | 0.0% | 0.00% | – |
| Q2 2022 | $489,000 | -40.0% | 186,971 | 0.0% | 0.00% | – |
| Q1 2022 | $815,000 | +8.1% | 186,971 | +6.3% | 0.00% | – |
| Q4 2021 | $754,000 | -4.7% | 175,853 | +11.9% | 0.00% | – |
| Q3 2021 | $791,000 | -17.3% | 157,116 | +1.2% | 0.00% | – |
| Q2 2021 | $956,000 | -50.8% | 155,281 | -41.5% | 0.00% | – |
| Q1 2021 | $1,943,000 | +10.6% | 265,545 | +22.9% | 0.00% | – |
| Q4 2020 | $1,756,000 | +50.5% | 216,039 | +46.1% | 0.00% | – |
| Q3 2020 | $1,167,000 | +102.3% | 147,827 | +39.4% | 0.00% | – |
| Q2 2020 | $577,000 | – | 106,012 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,430,270 | $10,134,226 | 3.30% |
| Westside Investment Management, Inc. | 528,310 | $2,203,060 | 0.63% |
| Acuitas Investments, LLC | 219,000 | $913,230 | 0.54% |
| EAM Investors, LLC | 256,623 | $1,070,118 | 0.21% |
| Parkman Healthcare Partners LLC | 165,000 | $688,050 | 0.13% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 110,016 | $458,767 | 0.08% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 300,000 | $1,251,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 271,462 | $1,131,997 | 0.03% |
| Quantum Private Wealth, LLC | 11,500 | $47,955 | 0.02% |
| CHICAGO TRUST Co NA | 16,700 | $69,639 | 0.02% |